Boards & Committees - Board of Directors


The ISHLT Board of Directors is comprised of 15 individuals: the four Officers (Past President, President, President-Elect, and Secretary-Treasurer) and eleven Directors, reflecting the geographic and disciplinary constituencies of the Society.

The Editor of the Journal of Heart and Lung Transplantion, the Medical Director of the Registry, the Annual Meeting Scientific Program Chair, the Chair of the Development Committee, and the Executive Director serve as ex-officio, non-voting members of the Board.



Duane Davis, MD, MBA (2017)
Florida Hospital
Orlando, FL, USA

Bio coming soon...

Maryl R. Johnson, MD (2018)
University of Wisconsin
Madison, WI, USA

Maryl R. Johnson, MD, received her medical degree from the University of Iowa College of Medicine where she also completed postgraduate training in Internal Medicine and Cardiovascular Diseases. She joined the faculty at Iowa and was instrumental in the establishment of a cardiac transplant program, serving as the Medical Director of Cardiac Transplantation from 1984-1988. Her subsequent career has been entirely devoted to the care of patients with heart failure and following cardiac transplantation. She served as the Associate Medical Director of the Cardiac Transplant Program at Loyola University Medical Center from 1988-1994, Associate Medical Director of the Rush Heart Failure and Cardiac Transplant Program from 1994-1997, and Medical Director, Heart Failure and Transplantation at Northwestern Memorial Hospital from 1998-2002. She moved to the University of Wisconsin as Medical Director of Heart Failure and Transplantation and Professor of Medicine in July 2002. Dr. Johnson's clinical interests are in the care of patients with severe congestive heart failure, including the use of mechanical circulatory support devices and cardiac transplantation. She has a particular interest in the treatment and outcome of congestive heart failure in women. Her research interests include the use of mechanical assistance in patients with severe heart failure and the coronary artery disease which develops in cardiac transplant recipients. She has also been an investigator in many of the multicenter trials evaluating new agents for the medical treatment of heart failure.

Hermann Reichenspurner, MD, PhD (2016)
University Heart Center Hamburg
Hamburg, GERMANY

Prof. Reichenspurner is currently the Medical Director, University Heart Center Hamburg, and Professor and Chairman of the Department of Cardiovascular Surgery. He was trained in Munich, Cape Town and Stanford University. He is actively involved in cardiac and pulmonary transplantation since 1985 and wrote his MD - and 2 PhD - theses about cardio-pulmonary transplantation and immunology. He and his team have published over 460 articles, many of those focusing on transplantation. In addition, he is the spokesman of the Federal Medical Chamber in Germany for heart and lung transplantation and Head of the University Transplant Center in Hamburg.

Stuart C. Sweet, MD, PhD (2016)
St. Louis Children's Hospital
St. Louis, Missouri, USA

Stuart Sweet, MD, is Professor of Pediatrics at Washington University and Medical Director of the Pediatric Lung Transplant Program at St. Louis Children’s Hospital in St. Louis, Missouri. He received graduate and medical degrees at the University of Michigan and post-graduate training at Washington University. His current research focuses on lung disease in children and improved understanding of the important factors determining outcome after lung transplantation. He is currently leading an NIH funded multicenter collaborative study of the role viral infections play in pediatric lung transplant. Dr. Sweet has active interests in organ allocation (he is currently Secretary of the OPTN/UNOS Board of Directors) and the use of information technology in medicine (he is chair of the Electronic Health Records committee at St. Louis Children's Hospital).


Carla C Baan, PhD (2017)
Erasmus Medical Center

Carla C. Baan, PhD, is Professor and head of the Nephrology & Transplantation Laboratory at Erasmus Medical Center, University Hospital Rotterdam, The Netherlands. Dr Baan obtained her doctorate from Erasmus University, The Netherlands. Her position involves the supervision of doctorate research related to the role of cytokines, regulatory T cells, B cells, cell therapy and immunosuppressive drugs in clinical organ transplantation. Dr Baan is the first Past President of the European Society for Organ Transplantation (2013-2015), and a member of the board of the International Society for Heart and Lung Transplantation (2015-2016), the Transplantation Society, the Dutch Transplantation Society, the Dutch Immunology Society and the Dutch Nephrology Society. Currently, Dr Baan is an editor of Transplantation Immunology and is the executive editor basic sciences of the Transplantation Journal.

Christian Benden, MD (2017)
University Hospital Zurich

Dr. Christian Benden is the Medical Director of Lung Transplantation at the University Hospital Zurich and a Reader in Pulmonology and Transplant Medicine at the University of Zurich, Switzerland. Dr. Benden completed his pediatric training in Hannover (Germany) and London (United Kingdom). In addition, he trained in Pediatric Pulmonology and received specialist training in lung transplantation in London and Zurich. Dr. Benden is a well-recognized Pediatric Lung Transplant Physician, and a former Chair of the ISHLT Scientific Council on Pediatric Transplantation. His research interests include clinical aspects of lung transplantation, particularly in children and adolescents, experimental aspects of chronic lung allograft dysfunction, and cystic fibrosis lung disease.

Lara Danziger-Isakov, MD, MPH (2017)
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, USA

Lara Danziger-Isakov, MD, MPH, practices pediatric infectious diseases at Cincinnati Children's Hospital Medical Center where she is Associate Professor of Pediatrics at the University of Cincinnati. Dr. Danziger-Isakov earned her MD at Case Western Reserve University School of Medicine and complete her residency in Pediatrics at the Cleveland Clinic. She also completed a fellowship in Pediatric Infectious Diseases at Saint Louis Children's Hospital. Dr. Danziger-Isakov is board-certified in Pediatrics and Pediatric Infectious Diseases by the American Board of Pediatrics. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised patients. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis on pediatric and adult lung transplantation. In addition, Dr. Danziger-Isakov participates in clinical trials to evaluate both new infectious disease therapies and new method of detection for infectious diseases.

Tobias Deuse, MD, PhD (2018)
University Heart Center Hamburg
Hamburg, GERMANY

Tobias Deuse is the Surgical Director of Heart and Lung Transplantation at the University Heart Center Hamburg, Germany. He completed his cardiothoracic residency in Munich and Hamburg, and completed a fellowship in Thoracic Transplantation and Mechanical Circulatory Support at Stanford University, California. His main clinical interests are minimally-invasive lung transplantation and minimally-invasive LVAD implantation. His research focus includes the development of new immunosuppressive/ immunomodulatory agents and alternative forms of administration like inhaled immunosuppression or cell-based immunomodulation. He is also active in the field of pluripotent stem cell research and tissue regeneration.

Andrew J. Fisher, FRCP, PhD (2016)

Freeman Hospital
Newcastle Upon Tyne, UK

Andrew Fisher is Academic Director and Honorary Consultant Respiratory and Transplant Physician at the Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne and Professor of Respiratory Transplant Medicine at Newcastle University Medical School. He graduated from Nottingham University in 1993 and received research training as an Medical Research Council training fellow in Newcastle and Edinburgh 1996-99. He was subsequently awarded a GlaxoSmithKline Senior Clinical Research Fellowship 2005-2010. He has previously served as Chair of the British Thoracic Society Science and Research Committee 2009-2012 and Chair of the European Respiratory Society Lung Transplant Group 2010-2013.

Daniel J. Goldstein, MD (2018)
Montefiore Medical Center
Bronx, New York, USA

Dr. Daniel J. Goldstein is a Professor at the Albert Einstein College of Medicine and Vice Chairman of the Department of Cardiothoracic Surgery at Montefiore Medical Center in New York where he also serves as the Director of the Mechanical Assistance Program. He is a graduate of the Mount Sinai School of Medicine (1991) and completed his general surgery and cardiothoracic surgery training at Columbia Presbyterian Medical Center in New York in 2000. While clinically active in all aspects of adult cardiothoracic surgery including coronary, valvular and aneurysmal heart disease, his clinical and research interests focus on the surgical management of end stage heart disease including stem cell therapies and pharmacological adjuncts for induction of left ventricular recovery in patients supported with left ventricular assist devices. Dr. Goldstein is an active member of the INTERMACS adverse event committee and has partaken as principal site investigator in multiple industry-based and NIH-supported clinical ventricular assist device trials.

Daniel R. Goldstein, MD (2016)
Yale New Haven Hospital
New Haven, CT, USA

As a physician-scientist and transplant immunologist, Dr. Goldstein examines how the innate immune system, in particular Toll-like receptors, impact alloimmunity and transplant tolerance. His work as a board certified transplant cardiologist affords him insights into whether preclinical immunological studies are relevant to solid organ transplantation. In addition, his research involves studies on how aging impacts innate immunity and the role of aging on alloimmmunity. In particular, his laboratory has discovered new pathways by which aging alters inflammation during acute viral infections, atherosclerosis, and information that age-induced inflammatory responses impact the tempo of acute allograft rejection and transplant tolerance.

Peter M. Hopkins, FRACP (2018)
The Prince Charles Hospital

Dr Peter Hopkins is the Director of the Quensland Lung Transplant Service and Associate Professor with the School of Medicine, University of Queensland, Brisbane. Research interests include First in Man clinical trials of innovative bronchoscopic techniques of lung volume reduction and development of novel treatment strategies for interstitial lung disease. Executive positions are held with the Australian Lung Foundation (PIVOT and the Australian IPF Registry), Deputy Chair of the Lung Standing Committee Transplant Society of Australia and New Zealand, Convenor SIG Interventional Bronchoscopy Thoracic Society of Australia and New Zealand and National Examiners Panel Royal Australian College of Physicians.

Myung H. Park, MD (2016)
Houston Methodist Hospital
Houston, TX, USA

Bio coming soon...

Michael G. Petty, PhD, RN, CNS (2018)
University of Minnesota Medical Center
Minneapolis, MN, USA

Dr. Michael Petty is the Cardiothoracic Clinical Nurse Specialist at the University of Minnesota Medical Center, Minneapolis, MN.  He received his initial nursing degree from St. Mary’s Junior College, Minneapolis, MN, and subsequently obtained a Bachelors Degree in Nursing from the University of the State of New York, and a Masters Degree and PhD in Nursing from the University of Minnesota.  He began his career as a staff nurse in the Surgical ICU at the University of Minnesota Hospital and Clinic, and has held a variety of clinical, administrative, and industry roles in the subsequent years.  Much of his focus and interest during that time has been in the care of patients with cardiovascular disorders requiring medical, surgical, and transplant interventions. He has been an active participant in the Mechanical Circulatory Support community since 1995 including serving as president of the International Consortium of Circulatory Assist Clinicians (ICCAC) in 2013.  His clinical research interests focus on thoracic transplant and family caregivers of MCS patients.

Jeffrey J. Teuteberg, MD (2017)
University of Pittsburgh/Presbyterian
Pittsburgh, Pennsylvania, USA

Jeffrey Teuteberg, MD, is an Assistant Professor of Medicine, Associate Director of the Cardiac Transplant Program, and a member of the Heart Failure/Cardiac Transplant section of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Medical Center, where he specializes in the care of patients with advanced cardiomyopathies, cardiac transplantation, ventricular assist devices and pulmonary hypertension. He has particular interests in advanced heart failure and the transition to cardiac transplantation and ventricular assist devices. Dr. Teuteberg graduated from the University of Chicago, Pritzker School of Medicine, in 1992 and remained at the University of Chicago for his Internal Medicine Residency and general Cardiovascular Fellowship, during which he spent a year as the Chief Medical Resident. Dr. Teuteberg received his Heart Failure and Cardiac Transplant training at Brigham and Women's hospital in Boston.


EDITOR-IN-CHIEF, Journal of Heart and Lung Transplantation
Mandeep R. Mehra, MD MBBS FACC FACP (2019)
Professor of Medicine, Harvard Medical School
Executive Director, Center for Advanced Heart Disease, Brigham and Women's Hospital
Boston, Massachusetts, USA

Dr. Mehra, an internationally recognized cardiologist with expertise in the treatment of heart failure and heart muscle damage, cardiac transplantation and mechanical circulatory devices, is professor of Medicine at Harvard Medical School and Executive Director of the Center for Advanced Heart Disease at the Brigham and Women's Hospital in Boston, MA (USA). He obtained his cardiovascular training at the Ochsner Clinic Foundation, where he sub-specialized in the field of advanced heart failure and cardiac transplantation. He is board certified in internal medicine and cardiovascular diseases. His specific research interests in cardiac transplantation focus on post-transplant coronary arterial disease, new immunosuppressive therapy to improve heart transplant outcomes, and bringing genomic and proteomic science (the study of protein interactions in the body) to the bedside. In the field of heart failure, his research has focused on the role of new devices and novel serum markers to guide diagnosis and therapy.

Josef Stehlik, MD, MPH (2017)
University of Utah
Salt Lake City, Utah, USA

Josef Stehlik, MD, MPH is an Associate Professor of Medicine at the University of Utah School of Medicine. Dr. Stehlik received his medical degree from Charles University in Prague and Masters in Public Health degree from Harvard School of Public Health. He completed his training in Internal Medicine and in Cardiovascular Diseases at Allegheny General Hospital, MCP*Hahnemann University and advanced training in Heart Failure and Transplantation at the Cleveland Clinic. Dr. Stehlik has been on faculty at the University of Utah since 2004 and serves as Medical Director of the Heart Transplant Program at the University of Utah Hospital and the Salt Lake City Veterans Affairs Medical Center. He has been active in clinical work, education and research in the areas of advanced heart failure, heart transplantation and mechanical circulatory support.

Christopher H. Wigfield, MD FRCS(C/Th) (2018)
The University of Chicago Medicine & Biological Sciences
Chicago, Illinois, USA

Christopher Wigfield, MD, MD, FRCS(C/Th), is Assistant Professor of Cardiothoracic Surgery at The University of Chicago. Dr. Wigfield received his clinical MD at Freie Universitaet Berlin, Germany and an additional Medical Sciences MD from the University of Newcastle upon Tyne, United Kingdom. He completed residencies in General Surgery at Royal Berkshire Hospital and at Freeman Hospital in the UK and went on to complete a fellowship in Cardiothoracic Surgery and Cardiopulmonary Transplantation at the Cardiothoracic Centre in Newcastle upon Tyne, UK. He also completed a Cardiothoracic Surgery fellowship at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin, USA. Dr. Wigfield's clinical and research interests are in thoracic surgery, lung transplantation, robotic assisted surgery and minimally invasive thoracic surgery. He has a dedicated educational portfolio.

Amanda W. Rowe (1992 - Present)
14673 Midway Rd., Suite 200
Addison, Texas, 75001

Bio coming soon...

Text SizeIncrease Font SizeDecrease Font Size